MedPath

NEUROTAU, INC.

NEUROTAU, INC. logo
🇺🇸United States
Ownership
Private
Established
2017-01-01
Employees
1
Market Cap
-
Website
https://neurotau.com

Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks

Phase 1
Conditions
Progressive Supranuclear Palsy
Interventions
Drug: Placebos
First Posted Date
2020-02-05
Last Posted Date
2020-02-05
Lead Sponsor
NeuroTau, Inc.
Target Recruit Count
24
Registration Number
NCT04253132
Locations
🇺🇸

Lou Ruvo Center for Brain Health - Cleveland Clinic Nevada, Las Vegas, Nevada, United States

© Copyright 2025. All Rights Reserved by MedPath